VCYT peer analysis
Veracyte (VCYT) against its competitors: price, today's move, 1-year return and market value side by side.
VCYT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDSX Biodesix | $23.25 | -5.93% | 253.96% | – |
| BIAF bioAffinity | $2.98 | 2.41% | -91.86% | – |
| BLLN BillionToOne | $107.48 | -5.15% | – | – |
| CSTL Castle Biosciences | $34.75 | -6.49% | 43.54% | $1.14B |
| GH Guardant Health | $170.73 | -4.51% | 84.75% | $23.99B |
| IMDX Insight Molecular Diagnostics | $2.96 | -6.92% | -50.04% | – |
| MYGN Myriad Genetics | $5.86 | -7.72% | -26.29% | $607.38M |
| NEO NeoGenomics | $16.57 | -4.63% | 71.05% | $2.25B |
| PSNL Personalis | $15.82 | 0.03% | 66.40% | $1.69B |
| WGS GeneDx | $64.47 | -6.65% | -50.97% | $2.06B |
| VCYT Veracyte | $49.31 | -1.40% | 39.57% | $4.02B |
- VCYT's peers: BDSX (Biodesix), BIAF (bioAffinity), BLLN (BillionToOne), CSTL (Castle Biosciences), GH (Guardant Health), IMDX (Insight Molecular Diagnostics), MYGN (Myriad Genetics), NEO (NeoGenomics).
Updated 2026-11-02 19:10 UTC